Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 120 of 155
-
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P161
-
Microarray analysis for molecular characterization of disease activity and measuring outcomes of anti-tumour necrosis factor therapy in rheumatoid arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P159 -
Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P157 -
Prevalence of non-rheumatoid arthritis-associated autoantibodies in sera of anti-cyclic citrulline antibody-positive patients
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P155 -
Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P153 -
Immunophenotype and functional characteristics of rheumatoid arthritis derived myeloid dendritic cells and plasmacytoid dendritic cells
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P151 -
Citrullinated peptide-specific CD19+B cells are present in synovial tissue and peripheral blood of patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P149 -
Investigation of the relationship between the HLADRB1 genotype and the presence of autoantibody to cyclic-citrullinated peptide in patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P147 -
Decreased binding of annexin V to endothelial cells: a novel mechanism of atherothrombosis in patients with systemic lupus erythematosus
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P143 -
FcγR-mediated uptake and processing of antigen–immunoglobulin complexes by professional antigen-presenting cells
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P141 -
Cytokine expression was assessed during antigen-induced arthritis in the synovial membrane, inguinal lymph node, and spleen using competitive RT-PCR and sandwich ELISA
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P124 -
Non-traditional risk and protective factors for cardiovascular disease in systemic lupus erythematosus
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P122 -
Exploring mechanisms of inflammatory hyperalgesia in murine collagen-induced arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P120 -
Patterns of gene expression in rheumatoid arthritis synovial tissue: inter-patient variability greater then intra-patient variability in a small study
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P116 -
Infliximab treatment does not induce apoptosis in peripheral blood mononuclear cells up to 24 hours after initiation of treatment in rheumatoid arthritis patients
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P114 -
Requirement of IL-17 receptor signaling in resident synoviocytes for development of full blown destructive arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P112 -
Regulation of myeloid cell function and MHC class II expression by tumor necrosis factor
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P110 -
Regulation of T-cell differentiation by IL-4R α-chain single nucleotide polymorphisms
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P108 -
Discrepancy between jun/fosproto-oncogene mRNA and protein expression in the rheumatoid arthritis synovial membrane
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P106 -
Genotype-dependent NOS-3 expression and rheumatoid arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P104 -
Identification of a natural soluble form of the IL-18 receptor accessory protein as an immunomodulator in experimental arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P89 -
Marked expression of IL-1 receptors in cell nuclei and muscle fiber membrane in muscle tissue of patients with idiopathic inflammatory myopathies
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P85 -
Differential expression of multidrug resistance-related proteins on monocyte-derived macrophages from rheumatoid arthritis patients
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P83 -
Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P81 -
Characterization of the IL-12 family of cytokines in human dendritic cells infected with live Chlamydia trachomatis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P79 -
Impaired early B-cell tolerance in patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P78 -
Sustained downregulation of the TCRζ chain defines a transition from antigen mode to inflammation mode during terminal T-cell differentiation
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P76 -
Arthroscopic lavage with methylprednisolone is superior compared with either treatment alone in patients with inflammatory arthritis of the knee: a randomized prospective trial
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P72 -
Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P68 -
Neutralizing IL-17 during re-activation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P53 -
Prevalence and specificity of autoantibodies to defensins in sera of patients with systemic autoimmune diseases
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P51 -
The persistence of abnormal T-cell differentiation patterns predicts relapse in rheumatoid arthritis patients with controlled disease
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P47 -
Effects of overexpression of PAD4 enzyme in mouse synovium
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P45 -
A role for IL-7 in regulating CD4+CD25high regulatory T cells
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P43 -
How does tumour necrosis factor uncouple T-cell receptor-induced IL-2 gene expression in murine T cells?
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P41 -
Regulatory T-cell defect in the arthritis-susceptible DBA/1 mouse
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P39 -
Functional regulatory immune responses against human cartilage glycoprotein-39 in health versus proinflammatory responses in rheumatoid arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P37 -
Expression of innate immune receptors in the immunopathologic lesion of primary Sjogren's syndrome: preliminary results
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P35 -
In systemic sclerosis, levels of tissue kallikrein are related to microvascular changes assayed by videocapillaroscopy and immunohistochemistry
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P33 -
Altered composition of CD97 splice variants in rheumatoid synovial tissue
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P16 -
Innate immunity and the anti-viral state of rheumatoid synovium
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):S16 -
Genetics and bone disease
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):S13 -
Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P12 -
Collagenases and aggrecanases: understanding the role of non-catalytic domains in cartilage matrix breakdown
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):S11 -
Peptide mimetics of anti-dsDNA idiotypes as a tool for lupus-specific IVIG preparation: specificity and efficacy in the treatment of experimental systemic lupus erythematosus
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P10 -
Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):S9 -
Short-fibre modification facilitates adenovirus-mediated gene delivery in rheumatoid arthritis synoviocytes and synovium: role of RGD and non-RGD binding integrins
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P8 -
Specificity of CD4 T-cell responses to aggrecan in BALB/c and DR1 transgenic mice
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P6 -
Prophylactic administration of abatacept (CTLA4-Ig; BMS-188667) prevents disease induction and bone destruction in a rat model of collagen-induced arthritis
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P4 -
Positive cytoplasmic indirect immunofluorescence on HEp2 cells of unknown pattern: what to report to rheumatologists
Citation: Arthritis Research & Therapy 2005 7(Suppl 1):P2